As of 3:59pm ET
| -0.28 / -7.49%|
The 1 analysts offering 12-month price forecasts for Immunomedics Inc have a median target of 1.50, with a high estimate of 1.50 and a low estimate of 1.50. The median estimate represents a -56.65% decrease from the last price of 3.46.
The current consensus among 2 polled investment analysts is to Buy stock in Immunomedics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.